SCHEMBL15538764

SCHEMBL15538764

CC(C)(F)CN1CCC(COc2ccc(-c3ccc(C(=O)O)c(F)c3)cc2CO)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 2/20 0.40
CHRM2 P08172 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
SCN7A Q01118 4/20 0.40
SSTR5 P35346 1/20 0.39
KCNH2 Q12809 1/20 0.39
SCN5A Q14524 3/20 0.38
RARA P10276 1/20 0.38
RARB P10826 1/20 0.38
FFAR4 Q5NUL3 3/20 0.38
SYK P43405 1/20 0.37
GPR119 Q8TDV5 2/20 0.37
SCN9A Q15858 2/20 0.37
SCN1A P35498 1/20 0.37
SCN4A P35499 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
SCN8A Q9UQD0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15538448 0.92 CHRM4 (0.43) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL16777099 0.90 PKM (0.40) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL20053623 0.90 SLC6A9 (0.39) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15539463 0.87 PIK3CA (0.39) SCN7ASCN5AGPR119SCN9ASCN1A
SCHEMBL15539462 0.87 PIK3CA (0.39) SCN7ASCN5AGPR119SCN9ASCN1A
SCHEMBL15539260 0.86 XDH (0.46) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL15538445 0.86 RARA (0.51) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL16803742 0.85 CNR2 (0.37) SCN7ASCN5AFFAR4GPR119SCN9A
SCHEMBL15538426 0.83 DYRK1A (0.43) CHRM4CHRM2CHRM5CHRM1CHRM3
SCHEMBL16757956 0.82 RARB (0.44) CHRM4CHRM2CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 CHRM4 669/4885CHRM2 432/4885CHRM5 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.